Navigation Links
Par Pharmaceutical Begins Shipment of Generic Zyprexa® Zydis®
Date:10/24/2011

ts higher-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press releases and other company information, visit www.parpharm.com.

Safe Harbor Statement

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. To the extent any statements made in this news release contain information that is not historical, these statements are essentially forward looking and, as such, are subject to known and unknown risks, uncertainties and contingencies, many of which are beyond the control of the Company, which could cause actual results and outcomes to differ materially from those expressed herein. Risk factors that might affect such forward-looking statements include those set forth in Item 1A of the Company's most recent Annual Report on Form 10-K, in other of the Company's filings with the SEC from time to time, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and on general industry and economic conditions. Any forward-looking statements included in this news release are made as of the date hereof only, based on information available to the Company as of the date hereof, and, subject to any applicable law to the contrary, the Company assumes no obligation to update any forward-looking statements.


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... MILAN , June 19, 2013 ... in fluctuating Parkinson,s disease (PD) patients as add-on ... clinically important improvement in motor symptoms in fluctuating ...   Newron Pharmaceuticals S.p.A. ("Newron"), a ... and pain therapies, and its partner Zambon S.p.A., ...
(Date:6/18/2013)... 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ... development and commercialization of novel bile acid therapeutics to ... an underwritten public offering of 1,730,000 shares of its ... per share.  In addition, Intercept has granted the underwriters ... 259,500 shares of common stock. All of ...
(Date:6/18/2013)... June 18, 2013 /PRNewswire-iReach/ -- Today E-T-A Circuit ... Appliance Inlet Module. The X3130, integrated with E-T-A,s ... a C14 appliance inlet module, rocker switch and ... three-in-one device allows design engineers to streamline the ... installation time by 66 percent - and reduce ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Three-in-One X3130 Appliance Inlet Module 2
... Resort/Medical Aesthetics Expo will feature new innovations that ...  These new products will be on display and demonstrated ... Jacob K. Javits Convention Center in New York. ... gives spa, aesthetic and wellness professionals the tools to ...
... LAKE ZURICH, Ill. and BETHESDA, Md., Sept. 10 ... and the life-saving blood therapies people rely on every ... in the United States, when donors are in short ... donation is even more important – and so is ...
Cached Medicine Technology:Spa & Resort/Medical Aesthetics Expo to Feature New Innovations from Exhibitors 2Spa & Resort/Medical Aesthetics Expo to Feature New Innovations from Exhibitors 3Spa & Resort/Medical Aesthetics Expo to Feature New Innovations from Exhibitors 4Spa & Resort/Medical Aesthetics Expo to Feature New Innovations from Exhibitors 5Honoring Those Who Collect Blood, Medicine's Most Vital Natural Resource 2Honoring Those Who Collect Blood, Medicine's Most Vital Natural Resource 3
(Date:6/19/2013)... early April, senior leaders from medical, law enforcement, military, ... one question: how can first responders improve survival after ... results of this discussion are now available in " ... ," a concept paper published in the June issue ... Acute Care Surgery , official publication of the ...
(Date:6/19/2013)... body,s system for repairing damage to the genetic material ... it may seem, those compounds are sparking optimism as ... a mutation in BRCA, a gene that made headlines ... The compounds, termed PARP inhibitors, are the topic of ... Chemical & Engineering News . C&EN is the weekly ...
(Date:6/19/2013)... Ariz. (PRWEB) June 19, 2013 PREFERRED ... WellCare of Arizona to offer a new ... Maricopa, Pima, La Paz, Yavapai and Mohave, Arizona counties. ... Mohave counties were effective January 1, 2013 and Maricopa ... 2014. , WellCare, Inc., the parent company of WellCare ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Kansas City will host ... Main Street Day . A section of Main Street in ... during the afternoon of the event. The Main Street Corridor ... event, which will help Kansas City join the ranks of dozens ... as a tool to foster community vibrancy and active lifestyles. , ...
(Date:6/19/2013)... Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig,s ... be classified into four distinct stages, report pathologists with ... Pennsylvania in the Annals of Neurology . This ... shows, for the first time, how the fatal degenerative ... central nervous system to other regions of brain and ...
Breaking Medicine News(10 mins):Health News:Hartford consensus aims to improve survival after mass shootings 2Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2
... have led people to re-examine their lifestyles and spend ... it is time to get to the basics of ... start their families now, instead of waiting for security. ... growing number of couples who are consulting fertility experts. ...
... 17 Bertalan Mesko, medical blogger and health 2.0 ... EchoJournal, a video site designed to present echocardiology videos ... team of one of the most famous medical blogs, ... users of other video sharing sites, including easy uploading, ...
... no reason to stop birth control , , FRIDAY, April 17 ... regularly and take birth-control pills may result in less muscle ... differences between women taking "the pill" and those not taking ... this point, the finding, from a study scheduled for presentation ...
... The University of Pittsburgh has received a five-year, ... Fogarty International Center to train researchers in regions of ... grant, part of the center,s AIDS International Training and ... training site in Mozambique, where there are an estimated ...
... 25 HARRISBURG, Pa., April 17 Health Secretary ... their time to help communities prepare for and respond ... important efforts. "National Volunteer Week starts Sunday and is ... sharing their time, energy and expertise to make Pennsylvania ...
... a leading Clinical Research Organization, announces it will present ... for April 21-24, 2009, in Washington, D.C. Dr. Sabine ... PRA, will chair the session, while Mark Nelson Tyrrell, ... of stakeholders for risk mitigation strategies." The discussion will ...
Cached Medicine News:Health News:Family Cocooning in the Face of Recession Leads to Expanded Business for Bay Area Fertility Doctor - Dr. Danielle Lane 2Health News:The Pill May Limit Muscle Gains in Women 2Health News:Pitt receives $2.8 million to train HIV/AIDS researchers in Mozambique, Brazil and India 2Health News:PA Secretary of Health Recognizes Pennsylvania Volunteers; Urges Greater Citizen Involvement 2Health News:PRA International to Present Key Challenges for Safety Professionals at the World Drug Safety Congress: PRA Experts discussing REMS at Washington DC Conference 2
Inquire...
The ACMI™ Operative Laparoscopy System is designed for single- and dual-incision CO2 laser procedures and is used with 45cm laparoscopic instruments....
Inquire...
Compact, economical Bactron II anaerobic environment system with air lock, workspace and a 200 plate capacity incubator delivers optimum productivity in a compact space....
Medicine Products: